Lyme disease

Researchers identify cell group key to Lyme disease arthritis

harminka — Thu, 04 Dec 2008 13:07:57 -0600

A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease.

Researchers track Lyme disease spirochetes

harminka — Fri, 20 Jun 2008 01:05:52 -0500

Microbiologists at the University of Calgary have demonstrated the first direct visualization of the dissemination of Borrelia burgdorferi, the bacterium that causes Lyme disease.

Lingering Bacteria Don't Indicate Chronic Lyme Disease

harminka — Tue, 01 Apr 2008 12:44:24 -0500

The bacteria that cause Lyme disease, the most common tick-borne illness in the United States, can linger in mouse tissues long after a full round of antibiotic treatment is completed, report researchers from the University of California, Davis.

Drug prevents dangerous tick diseases

harminka — Thu, 20 Mar 2008 14:19:18 -0500

Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology.

Study reveals inconspicuous hosts in Lyme disease epidemic

harminka — Fri, 30 Nov 2007 00:48:41 -0600

A study led by a University of Pennsylvania biologist in the tick-infested woods of the Hudson Valley is challenging the widely held belief that mice are the main animal reservoir for Lyme disease in the U.S.

Antibody responses in patients with Lyme arthritis

harminka — Wed, 28 Nov 2007 23:35:03 -0600

Lyme disease in the U.S. is caused by a form of bacteria, the spirochete Borrelia burgdorferi, infecting humans by tick bites.

First study of cognitive impairment due to chronic Lyme disease

harminka — Thu, 11 Oct 2007 10:12:17 -0500

Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.

New guideline for treating Lyme disease

harminka — Mon, 28 May 2007 03:43:09 -0500

A guideline developed by the American Academy of Neurology finds conventionally recommended courses of antibiotics are highly effective for treating nervous system Lyme disease. However, there is no compelling evidence that prolonged treatment with antibiotics has any benefit in treating symptoms that persist following standard therapy.

'Center for Hope' for Lyme Disease

Anastvatz — Thu, 26 Apr 2007 06:54:08 -0500

A First! Lyme Research Center Opens at Columbia Through Partnership with Lyme Disease Association and Time For Lyme

"Combination" Lyme Disease Vaccine Proteins Patented

harminka — Mon, 09 Apr 2007 13:38:37 -0500

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.